Literature DB >> 21285457

Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation.

Hyun-Jung An1, Young Jin Kim, Dong Hyun Song, Beom Suk Park, Ho Min Kim, Ju Dong Lee, Sang-Gi Paik, Jie-Oh Lee, Hayyoung Lee.   

Abstract

CD40 is a tumor necrosis factor receptor (TNFR) family protein that plays an important role in B cell development. CD154/CD40L is the physiological ligand of CD40. We have determined the crystal structure of the CD40-CD154 complex at 3.5 Å resolution. The binding site of CD40 is located in a crevice formed between two CD154 subunits. Charge complementarity plays a critical role in the CD40-CD154 interaction. Some of the missense mutations found in hereditary hyper-IgM syndrome can be mapped to the CD40-CD154 interface. The CD40 interaction area of one of the CD154 subunits is twice as large as that of the other subunit forming the binding crevice. This is because cysteine-rich domain 3 (CRD3) of CD40 has a disulfide bridge in an unusual position that alters the direction of the ladder-like structure of CD40. The Ser(132) loop of CD154 is not involved in CD40 binding but its substitution significantly reduces p38- and ERK-dependent signaling by CD40, whereas JNK-dependent signaling is not affected. These findings suggest that ligand-induced di- or trimerization is necessary but not sufficient for complete activation of CD40.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285457      PMCID: PMC3064178          DOI: 10.1074/jbc.M110.208215

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

Authors:  J Mongkolsapaya; J M Grimes; N Chen; X N Xu; D I Stuart; E Y Jones; G R Screaton
Journal:  Nat Struct Biol       Date:  1999-11

2.  A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.

Authors:  F K Chan; H J Chun; L Zheng; R M Siegel; K L Bui; M J Lenardo
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

3.  PHENIX: building new software for automated crystallographic structure determination.

Authors:  Paul D Adams; Ralf W Grosse-Kunstleve; Li Wei Hung; Thomas R Ioerger; Airlie J McCoy; Nigel W Moriarty; Randy J Read; James C Sacchettini; Nicholas K Sauter; Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-10-21

4.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

Authors:  S G Hymowitz; H W Christinger; G Fuh; M Ultsch; M O'Connell; R F Kelley; A Ashkenazi; A M de Vos
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

5.  Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154.

Authors:  L E Haswell; M J Glennie; A Al-Shamkhani
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

6.  CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.

Authors:  L L Pearson; B E Castle; M R Kehry
Journal:  Int Immunol       Date:  2001-03       Impact factor: 4.823

7.  Structure of CD40 ligand in complex with the Fab fragment of a neutralizing humanized antibody.

Authors:  M Karpusas; J Lucci; J Ferrant; C Benjamin; F R Taylor; K Strauch; E Garber; Y M Hsu
Journal:  Structure       Date:  2001-04-04       Impact factor: 5.006

8.  Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.

Authors:  Ho Min Kim; Kyung Sook Yu; Mi Eun Lee; Dong Ryeol Shin; Young Sang Kim; Sang-Gi Paik; Ook Joon Yoo; Hayyoung Lee; Jie-Oh Lee
Journal:  Nat Struct Biol       Date:  2003-05

9.  Ligand-receptor binding revealed by the TNF family member TALL-1.

Authors:  Yingfang Liu; Xia Hong; John Kappler; Ling Jiang; Rongguang Zhang; Liangguo Xu; Cheol-Ho Pan; Wesley E Martin; Robert C Murphy; Hong-Bing Shu; Shaodong Dai; Gongyi Zhang
Journal:  Nature       Date:  2003-05-01       Impact factor: 49.962

10.  The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations.

Authors:  Liwei Wang; Jin Kuk Yang; Venkataraman Kabaleeswaran; Amanda J Rice; Anthony C Cruz; Ah Young Park; Qian Yin; Ermelinda Damko; Se Bok Jang; Stefan Raunser; Carol V Robinson; Richard M Siegel; Thomas Walz; Hao Wu
Journal:  Nat Struct Mol Biol       Date:  2010-10-10       Impact factor: 15.369

View more
  44 in total

1.  Functional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 molecules.

Authors:  Youssef El Fakhry; Haydar Alturaihi; Daniel Yacoub; Lihui Liu; Wenyan Guo; Claire Leveillé; Daniel Jung; Lara Bou Khzam; Yahye Merhi; John A Wilkins; Hongmin Li; Walid Mourad
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

2.  CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor.

Authors:  Philippe P Pagni; Anitra Wolf; Mauro Lo Conte; Ronald Yeh; Guangsen Fu; Fa Liu; Matthias von Herrath; Ken Coppieters
Journal:  Diabetologia       Date:  2019-05-17       Impact factor: 10.122

Review 3.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

Review 4.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

5.  CD40-targeted peptide proposed for type 1 diabetes therapy lacks relevant binding affinity to its cognate receptor. Reply to Pagni PP, Wolf A, Lo Conte M et al [letter].

Authors:  Gisela M Vaitaitis; Michael H Olmstead; Dan M Waid; Jessica R Carter; David H Wagner
Journal:  Diabetologia       Date:  2019-07-08       Impact factor: 10.122

Review 6.  TNF superfamily protein-protein interactions: feasibility of small- molecule modulation.

Authors:  Yun Song; Peter Buchwald
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

7.  Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding.

Authors:  Aruna Bitra; Tzanko Doukov; Giuseppe Destito; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2018-12-13       Impact factor: 5.157

8.  Crystal structure of the human 4-1BB/4-1BBL complex.

Authors:  Ryan N Gilbreth; Vaheh Y Oganesyan; Hamza Amdouni; Shabazz Novarra; Luba Grinberg; Arnita Barnes; Manuel Baca
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

9.  Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.

Authors:  Aruna Bitra; Tzanko Doukov; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

10.  Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.

Authors:  Aruna Bitra; Tzanko Doukov; Jing Wang; Gaelle Picarda; Chris A Benedict; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-12-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.